Prothena Corporation is a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. Prothena Corporation was founded in 2012 and is based in Dublin, Ireland.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Prothena news
06.05.2022
Prothena's GAAP loss for 3 months of 2022 was $36.29 million, down 1.2% from $36.735 million in the previous year. Revenue increased 10-fold to $1.103 million from $0.11 million a year earlier.
Source: 
ir.prothena.com
ir.prothena.com
18.02.2022
Prothena's GAAP net income for 2021 was $66.975 million, compared to a loss of $111.144 million the previous year. Revenue increased multiple times to $200.577 million from $0.853 million a year earlier.
Source: ir.prothena.com
ir.prothena.com
05.11.2021
Prothena posted a GAAP net profit of $100.154 million for 9M 2021, compared to a loss of $80.428 million in the previous year. Revenue multiplied to $199.405 million compared to $0.493 million a year earlier.
Source: ir.prothena.com
ir.prothena.com
06.08.2021
Prothena's GAAP loss for six months of 2021 was $9.093 million, down 5.5 times from $49.851 million in the previous year. Revenue dropped multiple times to $60.231 million from $0.336 million a year earlier.
Source: ir.prothena.com
ir.prothena.com
General information
| Company name | Prothena |
|---|---|
| Tags | #pharmacy, #biotechnology |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Biotechnology / Biotechnology |
| Business address | 77 Sir John Rogersonâs Quay Block C Grand Canal Docklands Dublin 2 Ireland |
| Mailing address | 77 Sir John Rogersonâs Quay Block C Grand Canal Docklands Dublin 2 Ireland |
| Website | ir.prothena.com |
English (US) 